摘要
目的 综合分析痰热清注射液联合阿奇霉素序贯疗法治疗小儿支原体肺炎的疗效与安全性。方法选取本院2014年1月至2015年12月门诊儿科收治的240例支原体肺炎患儿，其中120例患儿采用阿奇霉素序贯治疗，作为对照组；另120例患儿采用痰热清注射液联合阿奇霉素序贯治疗，比较2组患儿的临床疗效和不良反应。结果实验组总有效率为97.50%，对照组为86.67%。实验组患儿发热、咳嗽、肺部啰音等临床症状消失时间显著短于对照组患儿，差异具有统计学意义(P<0.05)，但组间不良反应发生率差异无统计学意义(P＞0.05)。结论痰热清注射液联合阿奇霉素序贯疗法对治疗小儿支原体肺炎，临床疗效显著，值得推广使用。
Objective Comprehensive analysis of Tanreqing injection joint azithromycin sequential therapy efficacy and safety of children with mycoplasma pneumonia.Methods Our hospital between January2014and December2015outpatient pediatrics treated240cases of children with mycoplasma pneumonia,of which120cases of children with azithromycin sequential therapy,as control group.Another120cases with Tanreqing injection with azithromycin sequential therapy,compared two groups of children with clinical efficacy and adverse reactions.Results The total effective rate was97.50%,the control group was86.67%.Experimental group patients clinical symptoms such as fever,cough,lung's disappearance time significantly shorter than the control group were statistically significant difference(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The Tanreqing injection azithromycin sequential therapy in treating pediatric mycoplasma pneumonia,treatment,the total effective rate is high,is worth promoting
出处
《世界中医药》
CAS
2017年第A02期235-236,共2页
World Chinese Medicine
基金
国家中医药管理局中医药科学技术研究专项课题(国中医药科2013ZX04)-横向课题子课题.
关键词
痰热清注射液
阿奇霉素序贯疗法
小儿支原体肺炎
疗效分析
Tanreqing injection
Azithromycin sequential therapy
Children with mycoplasma pneumonia
Curative effect analysis
